{"name":"Alpine Immune Sciences, Inc.","slug":"alpine-immune-sciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALPN-303","genericName":"ALPN-303","slug":"alpn-303","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ALPN-303","genericName":"ALPN-303","slug":"alpn-303","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxObUs1WGxzSlJXUTBRSFBGRUxNdFg2THF1TnR3Y0pCTDA1enVLX0todGd4YjBoTE9KMDJyN1dtdEhnTFdGdkpvNVR1SFltQ0JqZkZfUnNabVVCMnRmZVpZNE9ORkVwWFdNVHJ6QjFSdUpKSV9zUmRfOU1XZWN6NGwzQ19SenM0QlRDZlFGbFl3M0VycVRnNl9LSkZKVHcxWkY3VzVWVlp2dUg2MzJTZmZibXBieG9FVVp1Z1NKbC02eVdacllVR19LeUFkN1lBZ0k?oc=5","date":"2024-05-20","type":"pipeline","source":"fenwick.com","summary":"Fenwick Represents Alpine Immune Sciences in its Acquisition by… - fenwick.com","headline":"Fenwick Represents Alpine Immune Sciences in its Acquisition by…","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQTGpkX0lfd0VpOUU4VTFTeFlxa2NLN3dsUEY0N3hhbHRLbmE5Y0NuQkJmYnhPcV9YcGVYZUtYXzRvT2RKNHZsYWVvanVmYmV4UUdEcXQ2cS10QVRsYzAwT19zOUtOeG5LemZqSE9NejluRFA1aDZCdGY3R0NadEtRMC1xNXRQckRtWWtHR18wT2pJdEZoaHZNd2FxNF80U3IyWnVIQlZpSTAxQXNhcG9rdWwtNA?oc=5","date":"2024-04-23","type":"trial","source":"Fierce Biotech","summary":"Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP - Fierce Biotech","headline":"Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWktCam9SUnp3cWI4b09IamRlUXlCcUMwOGpxYXRIWE01MVp5cGxLeWhLX2w0RW9hRUhOZ0RxY2ZMdlY5XzBRbzJnNDJsX2xPc0UzUE9XZ19sRW9QY0c2Nk9QM2hNQnpuMU5zNWlOcmM2LW5TSTFSeU5mcEpqU2E2LXBzSlo2MTRtc2FuWUVDazVzejhuZkZOZjlYQy1aTjdERkhOTlp5QU5JNGtKc0hYQ3VrZ0YxV1U?oc=5","date":"2024-04-11","type":"deal","source":"BioSpace","summary":"Vertex Buys Alpine for $4.9B to Bolster Autoimmune and Inflammatory Disease Pipeline - BioSpace","headline":"Vertex Buys Alpine for $4.9B to Bolster Autoimmune and Inflammatory Disease Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOTmwyTkc2MXNyQ2RsbF9KMlZnbXR4ZGpWLWVlREFoRENnQTJBX2l6SDktV1pyR1RDMXpPRWhYbk1sTDYzV3FEZVdrQk1yQlhQQzlnUFFyTl83ZVhtVTQxWkNieGJabU4tcWtBcWpBWEhFU1ZkRzVkZkdSMVNlT1F6X1duNVU0aFR0VTJuZzNVTUg4Y0lxc095ZkdCOFBlVEJYTmxz?oc=5","date":"2024-04-11","type":"deal","source":"Contract Pharma","summary":"Vertex Agrees to Acquire Alpine Immune Sciences for $4.9B - Contract Pharma","headline":"Vertex Agrees to Acquire Alpine Immune Sciences for $4.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOMWRHYjBITkQ3elFvaW9MSTE2d2lwOTVRQkJnZ05sMW9sb0MtbFZWUWNURFYxNlUyN19jLWw2ZDU3RkpxVDhsaGNmRGRVUk93d3AwM1dEa1NZNXdCYXA5cUhpTUNWbnNIYXhzb2tDTHN6UWI2NDhoN3RoVkxDMnRaSXE0Wk1ZNVM5QS1TUkE4ci1XY0tSeW5vMmxn?oc=5","date":"2024-04-11","type":"regulatory","source":"CHEManager","summary":"Vertex to Acquire Alpine Immune Sciences for $4.9 Billion - CHEManager","headline":"Vertex to Acquire Alpine Immune Sciences for $4.9 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOcmJveFhJdkg0cmVUVXRjRFhhOG9sZk1LcTNzMkRHTWtmSUthcXJ2XzNKSDJiZE5DQnpfMDI1Zm1CY0V0OXhYRnhSajBlS3BMT2o0WFdmMDRrQ3VlR2dsc25pQnA0ZzlwSlZELXNqV3lPcUxqM0JqVUdOeDlOMUdzVFJHZ3NkS1VmVjBlT2kxRThCTk0?oc=5","date":"2024-04-11","type":"deal","source":"Barron's","summary":"Vertex Pharmaceuticals to Buy Alpine Immune for $4.9B. What Wall Street Says. - Barron's","headline":"Vertex Pharmaceuticals to Buy Alpine Immune for $4.9B. What Wall Street Says. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxONVBGU0xmMW0xWlZIYXl1cDFXOWRuNVozRkNsZHlCU0dSdWIzOTNaTVBQcl9McmUwa0ZWamhMeVViLXlOVjk5UXcyMkQ0TXQxcEZvbno1UWowRDNGUDUzVU82aHNPRThmY0xJV2FCYUhkQTJ4NE9JVXdFRmhkUW4tZVNFMTEwSjZvaWRwY19welYtWEVydWNrMWRoR0NpT0drU3c?oc=5","date":"2024-04-11","type":"trial","source":"BioWorld News","summary":"Vertex buying Alpine for $4.9B for phase III-ready IgAN asset - BioWorld News","headline":"Vertex buying Alpine for $4.9B for phase III-ready IgAN asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQkdlckRVemJON0VleTJhN1kydl92ZGIzNmpLdi1jWjNjMEEtOUhsRU1RRlFTbUpoODZSVGZ4LVFrOXBEampsMzhkQ3VTWUg5QVozZUdhaE5LNnB4WGtmbXNSWEwwSUYzc1VtWC1icHltS3JNWkNzYmNCT2RndUg3VjMwVWpJeHZFUVUxc09QWEozOHg5cDFZeVFJMDhFNUVSbW55MUlWUkpKY24zcDNzQXhmLXotUVhic0RV?oc=5","date":"2024-04-10","type":"deal","source":"WSJ","summary":"Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion - WSJ","headline":"Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWE5PYzMwRmEzNGNPTkl3M2w3ZHlybjNlUzJ6R2VqeE5aMWlVSXlxNThqTkUxN0JtdmJKdGs4S0daM3J5LW5NSGZBcXpVbzZrNFB0b2oyV2tQTlBZTzhBWklsWmd1Rjd3S2tqcTVaYk5aM183SGJaQm9BZjZhZnh6bEpZTlhYM3NQLWpHWTJ5alpEaU9GZEdZdXBTUGQ4SWVjQTZLbUNQY0JKdw?oc=5","date":"2024-04-10","type":"deal","source":"Reuters","summary":"Vertex Pharma bets on kidney disease treatment with $4.9 bln Alpine Immune deal - Reuters","headline":"Vertex Pharma bets on kidney disease treatment with $4.9 bln Alpine Immune deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOS1ZtOEFSN3ZYNlZGM1Rya29fcGgwU2dNMUVpNDZJQm5RUmZGaGNlMlFmQzlyRUJxamxOYmdKX004WmpKZUY0cmZFRXk3Mmh3NjlSTWN1Rjh6ZUxOaEZoT2JQVTZmRHRuTWhRX1FzNjk2dmdFbXQ4Wm90TmUwRUE0ODg4VU95Q0VZcURBUmpWM2U5Qjk5aFpPVjE5b1FkQ1NXX0F1VGpMR21aYTctSDAyaG5EUF8?oc=5","date":"2024-04-10","type":"deal","source":"GeekWire","summary":"Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal - GeekWire","headline":"Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNOHpKMzFxSmZ0ekRrWGY4Q3BBRTZoWHJDZmxWcE9za01IcUwybWU0bVBtX0ZGOUk5TWFWNXZ6RnFiSnRNRjRxdWo1a3JmVE9DQTVxQ2RqamxZN3FvMk5ucl9BemVyOGUzX2RWeHh3cnllRE1jaUw0U3RZTTZDdlVmVHJJZUNLcUljdjAycnFrN3JBN0t1ZUVxYkNJa1BRbDhMOVVZb0ZJWkxDbGdTMVYyRjJ2ZG9FS0QyRzZ3Zkd5TE9mcDUxTGpZaTJlSQ?oc=5","date":"2024-04-10","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline - Genetic Engineering and Biotechnology News","headline":"Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOVVBBMWZoaFRWMllJSWtPSmZyVVhxTkR5X1dHclZ0QUpkb3ZFb1k3QWRLMGlOZFJ1ZGlJQVpMY1hjN01ENjhBNU43ckw2X3lmUk43VGltcGJUUTBQcm5KNzNCUUVhdXg3bWFFQmg5VUNOM0I1YnlZc1ZEemF1a29nMTFhd1RuY1pRLTdLNm1GVHJfVjh5ZWhxZXMwbENCMzRhMkRKS3M4ZFBkWXlZZmtOTUJTVFdIc3dKdnp3?oc=5","date":"2024-04-10","type":"deal","source":"businesswire.com","summary":"Vertex Enters Into Agreement to Acquire Alpine Immune Sciences - businesswire.com","headline":"Vertex Enters Into Agreement to Acquire Alpine Immune Sciences","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}